BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27654712)

  • 21. Changes in postoperative recurrence and prognostic risk factors for patients with gastric cancer who underwent curative gastric resection during different time periods.
    Kim DH; Kim SM; Hyun JK; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
    Ann Surg Oncol; 2013 Jul; 20(7):2317-27. PubMed ID: 23677605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression signature-based prognostic risk score in gastric cancer.
    Cho JY; Lim JY; Cheong JH; Park YY; Yoon SL; Kim SM; Kim SB; Kim H; Hong SW; Park YN; Noh SH; Park ES; Chu IS; Hong WK; Ajani JA; Lee JS
    Clin Cancer Res; 2011 Apr; 17(7):1850-7. PubMed ID: 21447720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic clustering of gastric carcinomas based on DNA methylation profiles at the precancerous stage: its correlation with tumor aggressiveness and patient outcome.
    Yamanoi K; Arai E; Tian Y; Takahashi Y; Miyata S; Sasaki H; Chiwaki F; Ichikawa H; Sakamoto H; Kushima R; Katai H; Yoshida T; Sakamoto M; Kanai Y
    Carcinogenesis; 2015 May; 36(5):509-20. PubMed ID: 25740824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for selection of patients at high risk of recurrence or death after complete surgical resection in stage I gastric cancer.
    Park JH; Ryu MH; Kim HJ; Ryoo BY; Yoo C; Park I; Park YS; Oh ST; Yook JH; Kim BS; Kang YK
    Gastric Cancer; 2016 Jan; 19(1):226-33. PubMed ID: 25614467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis.
    Tsai MH; Chen WC; Yu SL; Chen CC; Jao TM; Huang CY; Tzeng ST; Yen SJ; Yang YC
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1481-9. PubMed ID: 25968618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrating bioinformatics and clinicopathological research of gastrointestinal stromal tumors: identification of aurora kinase A as a poor risk marker.
    Yen CC; Yeh CN; Cheng CT; Jung SM; Huang SC; Chang TW; Jan YY; Tzeng CH; Chao TC; Chen YY; Yang CY; Ho CL; Fletcher JA
    Ann Surg Oncol; 2012 Oct; 19(11):3491-9. PubMed ID: 22588468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SFRP4 drives invasion in gastric cancer and is an early predictor of recurrence.
    Busuttil RA; George J; House CM; Lade S; Mitchell C; Di Costanzo NS; Pattison S; Huang YK; Tan P; Cheong JH; Rha SY; Boussioutas A
    Gastric Cancer; 2021 May; 24(3):589-601. PubMed ID: 33277667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pattern-Specific Transcriptomics Identifies
    Tanaka H; Kanda M; Miwa T; Tanaka C; Kobayashi D; Umeda S; Shibata M; Suenaga M; Hattori N; Hayashi M; Iwata N; Yamada S; Nakayama G; Fujiwara M; Kodera Y
    Mol Cancer Res; 2018 Sep; 16(9):1420-1429. PubMed ID: 29784667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.
    Pastore A; Jurinovic V; Kridel R; Hoster E; Staiger AM; Szczepanowski M; Pott C; Kopp N; Murakami M; Horn H; Leich E; Moccia AA; Mottok A; Sunkavalli A; Van Hummelen P; Ducar M; Ennishi D; Shulha HP; Hother C; Connors JM; Sehn LH; Dreyling M; Neuberg D; Möller P; Feller AC; Hansmann ML; Stein H; Rosenwald A; Ott G; Klapper W; Unterhalt M; Hiddemann W; Gascoyne RD; Weinstock DM; Weigert O
    Lancet Oncol; 2015 Sep; 16(9):1111-1122. PubMed ID: 26256760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer who underwent curative gastrectomy.
    Bilici A; Selcukbiricik F
    Tumour Biol; 2015 Aug; 36(8):6191-9. PubMed ID: 25761877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems.
    Allgayer H; Babic R; Gruetzner KU; Tarabichi A; Schildberg FW; Heiss MM
    J Clin Oncol; 2000 Jun; 18(11):2201-9. PubMed ID: 10829039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. REGIV as a potential biomarker for peritoneal dissemination in gastric adenocarcinoma.
    Moon JH; Fujiwara Y; Nakamura Y; Okada K; Hanada H; Sakakura C; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
    J Surg Oncol; 2012 Feb; 105(2):189-94. PubMed ID: 21780125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of PAK4 expression in gastric cancer.
    Kobayashi K; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Sato Y; Yanaka Y; Higuchi K; Aburatani T; Tomii C; Uetake H; Kojima K; Kawano T
    J Clin Pathol; 2016 Jul; 69(7):580-5. PubMed ID: 26614788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation of DLEC1 promoter is a predictor for recurrence in Chinese patients with gastric cancer.
    Ye X; Feng G; Jiao N; Pu C; Zhao G; Sun G
    Dis Markers; 2014; 2014():804023. PubMed ID: 25574068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer.
    Fondevila C; Metges JP; Fuster J; Grau JJ; Palacín A; Castells A; Volant A; Pera M
    Br J Cancer; 2004 Jan; 90(1):206-15. PubMed ID: 14710231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry.
    Wen YG; Wang Q; Zhou CZ; Yan DW; Qiu GQ; Yang C; Tang HM; Peng ZH
    J Surg Oncol; 2011 Oct; 104(5):516-24. PubMed ID: 21618246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical analysis of RTKs expression identified HER3 as a prognostic indicator of gastric cancer.
    Ema A; Yamashita K; Ushiku H; Kojo K; Minatani N; Kikuchi M; Mieno H; Moriya H; Hosoda K; Katada N; Kikuchi S; Watanabe M
    Cancer Sci; 2014 Dec; 105(12):1591-600. PubMed ID: 25455899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraoperatively assessed macroscopic serosal changes in patients with curatively resected advanced gastric cancer: clinical implications for prognosis and peritoneal recurrence.
    Yoo C; Ryu MH; Park YS; Yoo MW; Park SR; Ryoo BY; Jang SJ; Yook JH; Kim BS; Kang YK
    Ann Surg Oncol; 2015 Sep; 22(9):2940-7. PubMed ID: 25605515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting recurrence after curative resection for gastric cancer: External validation of the Italian Research Group for Gastric Cancer (GIRCG) prognostic scoring system.
    Barchi LC; Yagi OK; Jacob CE; Mucerino DR; Ribeiro U; Marrelli D; Roviello F; Cecconello I; Zilberstein B
    Eur J Surg Oncol; 2016 Jan; 42(1):123-31. PubMed ID: 26365755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A seven-gene signature can predict distant recurrence in patients with triple-negative breast cancers who receive adjuvant chemotherapy following surgery.
    Park YH; Jung HH; Do IG; Cho EY; Sohn I; Jung SH; Kil WH; Kim SW; Lee JE; Nam SJ; Ahn JS; Im YH
    Int J Cancer; 2015 Apr; 136(8):1976-84. PubMed ID: 25537444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.